TINA'S WISH AND RISING STAR GRANTEE DR. SARAH HILL FEATURED IN IMPACT SUMMER 2020

News

TINA’S WISH AND RISING STAR GRANTEE DR. SARAH HILL FEATURED IN IMPACT SUMMER 2020

TINA’S WISH AND RISING STAR GRANTEE DR. SARAH HILL FEATURED IN IMPACT SUMMER 2020

“Almost 80% of women with ovarian cancer are diagnosed at an advanced stage, when there is a diminished chance for a cure, according to the American Cancer Society. A test to detect ovarian cancer early could transform the outlook for this disease in the same way the Pap smear test has made cervical cancer almost completely preventable and treatable.

‘Pap smears reveal proteins and biomarkers that are being produced by precancerous and cancerous cells in the cervix,’ said Sarah Hill, MD, PhD, a researcher in Dana-Farber’s Susan F. Smith Center for Women’s Cancers. ‘Our goal is to identify biomarkers generated by cells in the ovaries or the fallopian tube to achieve the same level of prevention in ovarian cancer.'”

CLICK HERE to read more.

Tina’s Wish Researcher Dr. Sarah Hill is a gynecologic pathologist and an independent investigator at Dana-Farber Cancer Institute.

To learn more about Dr. Hill’s research, CLICK HERE.